Cite

HARVARD Citation

    Gerstner, E. et al. (2020). Vascular dysfunction promotes regional hypoxia after bevacizumab therapy in recurrent glioblastoma patients. Neuro-oncology advances. 2 (1), p. . [Online]. 
  
Back to record